GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.

Overview of attention for article published in Diabetes Care, November 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 67 news outlets
blogs: 5 blogs
twitter: 262 X users
patent: 1 patent
facebook: 3 Facebook pages

wikipedia: 7 Wikipedia pages
reddit: 60 Redditors
video: 3 YouTube creators
bluesky: 4 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 208 Mendeley

So far, Altmetric has seen 3 public wall posts from 3 users.

Ketogenic Generation, 08 Oct 2023

OBJECTIVE. To determine whether use of glucagon-like peptide 1 (GLP-1) receptor agonists (RA) is associated with increased risk…

Alternative Holistic Wellness Care, 12 Aug 2023

In the current study we found increased risk of all thyroid cancer and medullary thyroid cancer with use of GLP-1 RA, in…

Chris Beat Cancer, 28 Jun 2023

Ozempic and Wegovy increase risk of thyroid cancer. “Use of GLP-1 RA for 1-3 years was associated with increased risk of all…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.